JPMorgan analyst Eric Joseph downgraded HilleVax to Neutral from Overweight with a price target of $5, down from $24. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on HLVX: HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants JPMorgan ups HilleVax target, adds to Analyst Focus List HilleVax reports Q1 EPS (97c), consensus (84c) Disclaimer & DisclosureReport an Issue
